We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 35,304

A comparative study of strategies for patenting human therapeutics in the Asia Pacific Region: IP In Depth
  • Fisher Adams Kelly Callinans
  • Asia-Pacific, Australia
  • December 9 2016

In the last century, innovations in the life sciences have allowed for treatment and prevention of numerous diseases and disorders, enabling higher


Recent Patent Office decision provides further clarity in patentability of nucleic acids in Australia
  • Fisher Adams Kelly Callinans
  • Australia
  • December 9 2016

As has been widely reported, including in our previous articles such as this, the patentability or otherwise of isolated nucleic acids has been a


Australia & New Zealand to share single regime for Patent Attorney qualification and code of conduct after passage of Patents Amendment Bill
  • Fisher Adams Kelly Callinans
  • Australia, New Zealand
  • December 9 2016

Since 1996 it has been the case that Patent attorneys first registered in either Australia or New Zealand have been allowed to register separately to


Supreme Court Takes Small Bite of Apple, Leaves Bigger Questions Aside on Design Patent Damages
  • Bradley Arant Boult Cummings LLP
  • USA
  • December 8 2016

A unanimous Supreme Court held in Samsung Electronics Co. v. Apple Inc. that Section 289 of the Patent Act does not demand that the entire, infringing


Enablement and examination post raising the bar
  • FPA Patent Attorneys
  • Australia
  • December 8 2016

The amendments to the Patents Act under Raising the Bar brought changes to the enablement provisions required by Australian patent specifications


Cuozzo and Inter Partes Review: Are Patents Getting Easier to Invalidate?
  • Workman Nydegger
  • USA
  • December 8 2016

Recently, the Supreme Court decided the issue of whether the decision of the USPTO to institute an inter partes review (IPR) of claims from which a


Scotus: Damages for Design Patents can be based on parts
  • Valea AB
  • USA
  • December 7 2016

The Supreme Court of the United States (SCOTUS), by unanimous decision, reversed yesterday a damages award against Samsung of approximately $400, in


The Supreme Court Hears Oral Argument On Infringement Liability For U.S. Exporters Under
  • Fitzpatrick, Cella, Harper & Scinto
  • USA
  • December 7 2016

On December 6, 2016, the Supreme Court heard oral argument on the interpretation and application of 35 U.S.C. 271(f)(1) in Life Technologies Corp


U.S. Supreme Court Issues Samsung v. Apple Opinion - "Article of Manufacture" Can Be Less than an Entire Multicomponent Product
  • Fried Frank Harris Shriver & Jacobson LLP
  • USA
  • December 7 2016

The U.S. Supreme Court issued a unanimous decision in Samsung v. Apple on Tuesday, December 6, 2016, less than two months after oral arguments. This


Survey of the Safe Harbor in the United States and Europe
  • Fish & Richardson PC
  • Australia, European Union, United Kingdom, USA
  • December 7 2016

On October 3, 2016, the United States Supreme Court denied Amphastar Pharmaceutical's petition for certiorari regarding the so-called "safe harbor,"